- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Human reovirus type 3 Dearing strain
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Human reovirus type 3 Dearing strain
| EU orphan designation number: | EU/3/15/1469
|
| Active ingredient: | Human reovirus type 3 Dearing strain |
| Indication: | Treatment of ovarian cancer |
| Sponsor: | Oncolytics Biotech (UK) Limited
c/o McCarthy Tetrault, 125 Old Broad Street, London EC2N 1AR, United Kingdom |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 23/03/2015 | Orphan designation | EMA/OD/304/14 | (2015)2038 of 19/03/2015 |
CONTACT
EU links
Directorate General Health & Consumers